Asciminib provides long-term, durable molecular responses in patients with T3151-mutated CML-CP: Final analysis from a phase 1 trial Meeting Abstract
| Authors: | Cortes, J. E.; Rea, D.; Mauro, M. J.; Hochhaus, A.; Kim, D. W.; Sasaki, K.; Lang, F.; Heinrich, M. C.; Breccia, M.; Deininger, M. W.; Goh, Y. T.; Janssen, J. J. W. M.; Talpaz, M.; De Soria, V. G. G.; le Coutre, P.; Mahon, F. X.; Deangelo, D.; Kapoor, S.; Sanchez-Olle, G.; Cao, M.; Agrawal, N.; Hughes, T. P. |
| Abstract Title: | Asciminib provides long-term, durable molecular responses in patients with T3151-mutated CML-CP: Final analysis from a phase 1 trial |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 1765 |
| End Page: | 1766 |
| Language: | English |
| ACCESSION: | WOS:001414842000029 |
| DOI: | 10.1182/blood-2024-209537 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Hybrid event -- Source: Wos |
